Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Jiedu Shengji Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by the Southern Medical University Hospital of Integrative Medicine. It is specifically designed for the prevention and treatment of radiation-induced vaginal injury, a common complication in patients undergoing radiotherapy for gynecological cancers such as cervical cancer. The formula is based on TCM principles where "Qingre" (clearing heat) and "Jiedu" (detoxifying) aim to reduce radiation-induced inflammation and oxidative stress, while "Shengji" (generating muscle) focuses on promoting the repair and regeneration of the vaginal mucosal epithelium. The treatment is typically administered topically or via vaginal irrigation to alleviate symptoms like vaginal dryness, pain, and mucosal thinning or ulceration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingre Jiedu Shengji Fang.